BMSSC
PCVX icon

B. Metzler seel. Sohn & Co’s Vaxcyte PCVX Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Hold
17,235
– – 0.01% 574
2026
Q1 		$1M Buy
+17,235
New +$936K 0.01% 548
2024
Q4 		– Sell
-10,409
Closed -$1.19M – 775
2024
Q3 		$1.19M Hold
10,409
– – 0.01% 512
2024
Q2 		$786K Buy
+10,409
New +$709K 0.01% 565

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

B. Metzler seel. Sohn & Co's PCVX Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co held its Vaxcyte (PCVX) position steady in Q2 2026 at 17,235 shares worth $1M. The position accounts for 0.01% of the portfolio, ranked #574.

B. Metzler seel. Sohn & Co first reported a position in PCVX in Q2 2024 and has held it in 4 quarters since. The position peaked at $1.19M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 17,235 shares of Vaxcyte worth $1M as of Q2 2026.
  • B. Metzler seel. Sohn & Co left its Vaxcyte share count unchanged in Q2 2026.
  • Vaxcyte made up 0.01% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #574 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Vaxcyte in Q2 2024 and has held it in 4 quarters since.
  • B. Metzler seel. Sohn & Co's Vaxcyte position peaked at $1.19M in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.